CDMO Readiness Is More Than A Data Package

This segment of the Outsourced Pharma Live event, “Charting A Direct Pathway From Academia To CDMOs,” explains why readiness involves more than reaching a scientific milestone or assembling data. Michael and Leonardo discuss the need for academic teams to dedicate staff and time to the transfer, engage actively with the CDMO, and adopt a new mindset centered on compliance, quality, process robustness, and GMP expectations. Featuring Michael Salgaller, Ph.D., Supervisor, Technology Analysis and Marketing Unit, Technology Transfer Center at NCI, NIH, and Leonardo Sibilio, Ph.D., CEO, Nexantia Biotherapeutics.